Send Enquiry

CURE
Tablets
Packaging and packing Type
Blister | 10x15
MRP :
₹100
PTR :
₹76.19
PTS :
₹68.57
Prescription medicine Read More
Composition
Send Enquiry
Available on PCD franchise with monopoly rights: Cardiac and diabetic PCD franchise
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Viglim MP2 is an anti-diabetic tablet from Vibcare Pharma's C.U.R.E division. Each tablet has Glimepiride 2 mg, Pioglitazone 15 mg and Metformin 500 mg. It belongs to the class of oral anti-diabetic combinations containing a sulfonylurea, a thiazolidinedione and a biguanide. The product is packed as 10x15 (Blister).
Glimepiride makes the pancreas release more insulin into the blood. Pioglitazone raises the sensitivity of the body's cells to insulin, so more glucose moves out of the blood, and it also lowers glucose output from the liver. Metformin cuts the glucose produced by the liver and helps the body handle its own insulin with greater efficiency. Together the three act on different points of blood sugar control.
These tablets are used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. Glimepiride can cause severe low blood sugar, so patient selection, dosing and monitoring need care, especially in the elderly and in kidney impairment. Pioglitazone can cause or worsen heart failure and fluid retention; watch for rapid weight gain, breathlessness and swelling, particularly after starting treatment or after a dose change. Liver injury has been reported, so tell the doctor at once about nausea, vomiting, stomach pain, dark urine or jaundice. Metformin can rarely cause lactic acidosis, with risk factors like kidney problems, heavy alcohol intake, liver disease, old age, surgery and contrast X-ray studies.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
For distributors and medical representatives
Viglim MP2 Tablet is part of Vibcare Pharma's cardiac and diabetic range. Take the range to your area as a PCD franchise partner, with monopoly rights in your district.
Cardiac and diabetic PCD franchisePCD pharma franchise with Vibcare
Viglim MP2 tablets combine glimepiride, pioglitazone and metformin to improve blood sugar control in adults with type 2 diabetes. Main uses: adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus; used when blood sugar control is not reached with a single anti-diabetic medicine; not for type 1 diabetes mellitus; not for diabetic ketoacidosis.
Common side effects of Viglim MP2 Tablet include low blood sugar (hypoglycaemia); headache; nausea; dizziness; weight gain; swelling of the feet or ankles (fluid retention). Get medical help at once if you notice severe low blood sugar; congestive heart failure or worsening of existing heart failure; lactic acidosis (rare, related to metformin).
Each Viglim MP2 tablet contains Glimepiride 2 mg + Pioglitazone 15 mg + Metformin 500 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Viglim MP2 Tablet only as your doctor advises.
The MRP of Viglim MP2 Tablet is ₹100 for a pack of 10x15 (Blister). For chemists and distributors, the PTR is ₹76.19 and the PTS is ₹68.57.
Each Viglim MP2 tablet contains Glimepiride 2 mg + Pioglitazone 15 mg + Metformin 500 mg. It comes in a pack of 10x15 (Blister).
Glimepiride makes the pancreas release more insulin into the blood. Pioglitazone raises the sensitivity of the body's cells to insulin, so more glucose moves out of the blood, and it also lowers glucose output from the liver. Metformin cuts the glucose produced by the liver and helps the body handle its own insulin with greater efficiency. Together the three act on different points of blood sugar control.
Must not be used for type 1 diabetes mellitus or diabetic ketoacidosis. Must not be used by patients allergic to glimepiride, sulfonamide derivatives, pioglitazone, metformin or any ingredient of the tablet. Must not be used in severe kidney impairment or in metabolic acidosis. Must not be used in patients with established NYHA Class III or IV heart failure; check with a doctor first if you have any heart problem. Must not be used in patients with active bladder cancer; check with a doctor first if you have liver disease, a past history of bladder cancer, glucose-6-phosphate dehydrogenase (G6PD) deficiency, drink alcohol heavily, or are elderly or going for surgery or contrast X-ray studies.
Viglim MP2 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner